Breast cancer preventative reported to weaken bones
By Robin Wulffson MD for eMaxHealth.com
A common fear among women is to be stricken with breast cancer. A drug that would reduce or eliminate that risk sounds very appealing. However, a product that sounds too good to be true may be just that. Exemestane (Aromasin) is a new drug that researchers hoped might provide a safe way to prevent breast cancer; however, a new study has reported that the medication is associated with a risk for significant bone loss.